miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review)

被引:2
|
作者
Mu, Hongxiang [1 ]
Zhang, Wenmao [1 ]
Qiu, Ye [1 ]
Tao, Ting [1 ]
Wu, Hongliang [1 ]
Chen, Zhuo [1 ]
Xu, Gaosheng [1 ]
机构
[1] Yueyang Maternal & Child Hlth Hosp, 693 Baling Rd, Yueyang 414000, Hunan, Peoples R China
基金
湖南省自然科学基金;
关键词
breast cancer; microRNA; biomarker; signaling pathway; treatment and prognosis; KAPPA-B; PATHWAY; PROLIFERATION; CELLS;
D O I
10.3892/ijo.2021.5196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer (BC) is one of the most common malignancies affecting women. BC is a heterogeneous disease that involves multiple oncogenic pathways and/or genetic alterations. MicroRNAs (miRNAs or miRs) are a type of small endogenous single-stranded RNA that pairs with the 3 ' untranslated region of target mRNAs to negatively regulate the gene expression of specific mRNA targets. miRNAs are thus involved in various cellular processes, including proliferation, differentiation, apoptosis, migration, metabolism and the stress response. Over the past decade, a number of studies have demonstrated that the expression levels of miRNAs are dysregulated in a number of types of cancer, including BC. In the present review, recent research on miRNAs involved in the occurrence and development of BC, as well as the current findings on miRNAs as potential biomarkers for BC are summarized. In addition, the association between miRNA dysregulation and BC development, and the current status of BC treatment and prognosis are discussed. Finally, several signaling pathways involved in the development of BC and the potential roles of miRNAs in these pathways are reviewed. The present review aims to provide insight into the roles of miRNAs in BC.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Aberrant Expression, and Potency as Cancer Markers/Targets, of Splicing Regulators in Breast Cancer
    Lacroix-Triki, M.
    Dupuy, J. F.
    Dalenc, F.
    Dejean, S.
    Besse, P.
    Roche, H.
    Rochaix, P.
    Vagner, S.
    MODERN PATHOLOGY, 2009, 22 : 53A - 53A
  • [42] Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (Review)
    Ye, Lin
    Bokobza, Sivan M.
    Jiang, Wen G.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 (05) : 591 - 597
  • [43] A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression
    Abd Hamid, Umi M.
    Royle, Louise
    Saldova, Radka
    Radcliffe, Catherine M.
    Harvey, David J.
    Storr, Sarah J.
    Pardo, Maria
    Antrobus, Robin
    Chapman, Caroline J.
    Zitzmann, Nicole
    Robertson, John F.
    Dwek, Raymond A.
    Rudd, Pauline M.
    GLYCOBIOLOGY, 2008, 18 (12) : 1105 - 1118
  • [44] IMMUNOLOGICAL MARKERS FOR BREAST CANCER - REVIEW
    Barak, V.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1962 - 1962
  • [45] Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
    Madhavan, Dharanija
    Zucknick, Manuela
    Wallwiener, Markus
    Cuk, Katarina
    Modugno, Caroline
    Scharpff, Martina
    Schott, Sarah
    Heil, Joerg
    Turchinovich, Andrey
    Yang, Rongxi
    Benner, Axel
    Riethdorf, Sabine
    Trumpp, Andreas
    Sohn, Christof
    Pantel, Klaus
    Schneeweiss, Andreas
    Burwinkel, Barbara
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5972 - 5982
  • [46] Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
    Wong, Jun Sheng
    Cheah, Yoke Kqueen
    NON-CODING RNA, 2020, 6 (03) : 1 - 39
  • [47] Contribution of Stemness-Linked Transcription Regulators to the Progression of Breast Cancer
    Segura-Bautista, David
    Maya-Nunez, Guadalupe
    Aguilar-Rojas, Arturo
    Huerta-Reyes, Maira
    Allan Perez-Solis, Marco
    CURRENT MOLECULAR MEDICINE, 2022, 22 (09) : 766 - 778
  • [48] Unlocking the Potential of Circulating miRNAs in the Breast Cancer Neoadjuvant Setting: A Systematic Review and Meta-Analysis
    Tiberio, Paola
    Gaudio, Mariangela
    Belloni, Silvia
    Pindilli, Sebastiano
    Benvenuti, Chiara
    Jacobs, Flavia
    Saltalamacchia, Giuseppe
    Zambelli, Alberto
    Santoro, Armando
    De Sanctis, Rita
    CANCERS, 2023, 15 (13)
  • [49] Evaluation of tumorigenesis-related miRNAs in breast cancer in Egyptian women: a retrospective, exploratory analysis
    Salum, Ghada M.
    Elaraby, Nesma M.
    Ahmed, Hoda A.
    Abd El Meguid, Mai
    Fotouh, Basma E.
    Ashraf, Muhammed
    Elhusseny, Yasmine
    Dawood, Reham M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Selenoproteins in Tumorigenesis and Cancer Progression
    Short, Sarah P.
    Williams, Christopher S.
    SELENIUM AND SELENOPROTEINS IN CANCER, 2017, 136 : 49 - 83